Published Healthcare & Pharmaceuticals C3a Receptor Modulators University of Queensland researchers have developed series of novel, potent and selective, small organic molecules that mimic C3a (agonists) or inhibit its action (antagonists) By The University of Queensland
Published Manufacturing & Production Yeast expression booster Technology for targeted and stable integration of a gene in a manner that affords control of copy number and increased protein expression compared to standard yeast systems By The University of Queensland
Published Education & Training YOLO A web-based, scalable psychological intervention, tailored specifically for mental health distress commonly experienced by university students. By The University of Queensland
Published Software & Platforms iAx A simple and easy-to-use software that digitally collects patient responses to evidence-based questionnaires By The University of Queensland
Published Healthcare & Pharmaceuticals Modulators of Class IIa HDACs UQ has exploited structural differences between Class I and IIa HDACs to develop two generations of new compounds that are potent and selective inhibitors of class IIa HDACs. By The University of Queensland
Published Healthcare & Pharmaceuticals Vaccine for autoimmune disease Vaccination against viruses (eg EBV/CMV) could intercept progression of certain AI diseases. Clec9a-targeted liposomes (tailorable payloads) generate a robust CD141+ DC1 response. By The University of Queensland
Published Healthcare & Pharmaceuticals IBD Therapeutic Novel class of NF-κβ inhibitory bioactives identified from gut bacteria and developed into molecules that alleviates colitis in a murine model of inflammatory bowel disease. By The University of Queensland
Published Healthcare & Pharmaceuticals ACE2 Peptide Agonist for CKD ACE2 agonist with anti-fibrotic and anti-inflammatory activity, and that controls blood glucose levels in diabetic mouse models; potential to treat diabetic organ disease. By The University of Queensland
Published Food & Beverage ProGel Alginate Encapsulation Micro-gel encapsulation of actives and food supplements requiring liquid stable, low cost, scaleable manufacture. Continuous manufacture of alginate microgels in aerosol form By The University of Queensland
Published Medical Nav1.7 Inhibitor Pharmacological inhibition of Nav1.7 is a promising therapeutic strategy for the treatment of some pain disorders caused by mutations of SCN9A, the gene encoding Nav1.7 By The University of Queensland
Published Medical PAR2 Antagonists Orally active small molecule antagonists of the human protease-activated receptor 2 developed for potential treatment of inflammatory diseases, metabolic syndrome & cancer By The University of Queensland
